ATRC
AtriCure
–
Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 1.69B; Volume: 701.72K; AvgVol 3m: 317.08K; Beta: 0.72;
Cost estimate:
P/E: –; EPS: -1.29; EPS growth quarter/prev quarter: -80.00%;
EPS growth this year: -43.20%; EPS growth past 5 years: -8.80%;
EPS ttm: -1.29;
P/S: 8.48; P/B: 3.96; P/Cashflow: 7.73; P/FCF: ;
Sales: 211.98M; Sales growth quarter/prev quarter: -30.70%; Sales growth past 5 years: 16.50%;
Profitability:
Gross Margin: 72.20%; Profit Margin: -23.60%; Operating Margin: -22.10%;
ROA – return on assets: -8.50%; ROE – return on equity: -17.40%; LT Debt/Equity: 0.16; Total Debt/Equity: 0.16;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 2.70%; Insider Transactions:-8.23%;
Institutional Ownership: 95.60%; Institutional Transactions: 15.25%;
Data update: 07/10/2020.